Greg Cote, MD, PhD, medical oncologist, and early-stage clinical trialist from Mass General Cancer Center joined us on July 27, 2024, to provide an in-depth look at the drug development process and discuss the landscape of clinical trials that include patients with epithelioid hemangioendothelioma (EHE).
This webinar is essential for patients, families, healthcare providers, and researchers interested in the latest treatment options and advancements in EHE management. Attendees will gain valuable insights into how new drugs are brought to the market and learn about opportunities to participate in ongoing clinical trials recruiting EHE patients.